HEMISPHERIC RAISES $52M FOR BRAIN-ACTIVITY AI

Hemispheric's technology processes brain activity data collected through non-invasive methods—such as EEG or similar monitoring techniques—and applies machine learning to generate measurable diagnostic insights. The funding round underscores growing investor interest in AI-driven neurological diagnostics. The company's approach addresses a key challenge in neurology: translating raw brain signals into actionable clinical data. Quantifying brain activity could accelerate diagnosis of neurological conditions, potentially reducing reliance on subjective clinical assessment. The technology may find applications across psychiatric, neurological, and cognitive health domains. Hemspheric joins a wave of Israeli medtech startups leveraging AI for disease detection and patient monitoring. The company's non-invasive methodology positions it for scalable deployment across healthcare settings.